Full article: Novel multi-target ligands of dopamine and serotonin

Por um escritor misterioso

Last updated 04 abril 2025

Full article: Novel multi-target ligands of dopamine and serotonin

Computational approaches for the design of novel dopamine D2 and serotonin 5-HT2A receptor dual antagonist towards schizophrenia

Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer's Disease

Biomedicines, Free Full-Text

Frontiers Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression?

Full article: Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds–synthesis, biological activity, and structural evaluation

Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT6 receptor antagonists. Design, synthesis and biological evaluation - ScienceDirect

PDF) Computer-aided design of multi-target ligands at A1R, A2AR and PDE10A, key proteins in neurodegenerative diseases

Design, synthesis and biological evaluation of novel serotonin and dopamine receptor ligands being 6-bromohexyl saccharine derivatives - ScienceDirect

Recomendado para você